Follow Us
https://www.thebody.com/article/closer-look-egrifta-newly-approved-treatment-hiv-associated-belly
Body Fat, Lipodystrophy and HIV

A Closer Look at Egrifta, a Newly Approved Treatment for HIV-Associated Belly Fat Gain (Lipohypertrophy)

An Interview With Daniel Berger, M.D.

    Daniel S. Berger, M.D.
    Daniel Berger, M.D.
    Myles Helfand

    Myles Helfand

    @MylesatTheBody

    Myles Helfand is the executive editor and general manager of TheBody/TheBodyPro.